General Information of the Compound
| Compound ID |
CP0386341
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-(5-chloro-4-(1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-yl)-1H-imidazole
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C15H13ClN4
|
||||||||||||||||||
| Molecular Weight |
284.75
|
||||||||||||||||||
| Canonical SMILES |
Clc1ccc2C(CCc2c1-c1cn[nH]c1)c1ncc[nH]1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C15H13ClN4/c16-13-4-3-10-11(14(13)9-7-19-20-8-9)1-2-12(10)15-17-5-6-18-15/h3-8,12H,1-2H2,(H,17,18)(H,19,20)
Show/Hide
|
||||||||||||||||||
| InChIKey |
JMAPPYYTLHLIJH-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01089, Alpha-1A adrenergic receptor
Protein ID: PT01007, Alpha-1B adrenergic receptor
Protein ID: PT01004, Alpha-1D adrenergic receptor
Protein ID: PT01650, Alpha-2A adrenergic receptor